What do the research reports say?

Accutane was released on to the market in 1982 after extensive clinical testing. The cumulative research shows that this drug can be effective at lower dosages and the original manufacturer’s recommended dosing instructions have now been modified. All treatment with this drug begins at lower levels. Only if the response is unsatisfactory, will a higher dose be tried. Research also shows a good response in both capsule form and as a topical cream rubbed on to the affected area. With clinical trials continuing to explore whether Accutane may be used to deal with other skin disorders, there is now a significant body of work confirming excellent responses with lesions healing well and no significant residual scarring.

What do physicians say?

With such a long track record, physicians now trust Accutane to produce good results. Acne can cause significant emotional distress to those affected. Treating the physical condition is therefore important to improve mood and restore quality of life. Because this is a powerful medication, many countries require physicians to consult with dermatologists before prescribing this drug. It is not for everyone and its use should be carefully monitored. That said, there is no better drug on the market as a fallback when the other first-line drugs have failed.